Advertisement

International Journal of Clinical Pharmacy

, Volume 36, Issue 4, pp 675–678 | Cite as

Measuring the impact of long-term medicines use from the patient perspective

  • Janet KrskaEmail author
  • Charles W. Morecroft
  • Philip H. Rowe
  • Helen Poole
Commentary

Abstract

Polypharmacy is increasing, seemingly inexorably, and inevitably the associated difficulties for individual patients of coping with multiple medicines rise with it. Using medicines is one aspect of the burden associated with living with a chronic condition. It is becoming increasingly important to measure this burden particularly that relating to multiple long-term medicines. Pharmacists and other health professionals provide a myriad of services designed to optimise medicines use, ostensibly aiming to help and support patients, but in reality many such services focus on the medicines, and seek to improve adherence rather than reducing the burden for the patient. We believe that the patient perspective and experience of medicines use is fundamental to medicines optimisation and have developed an instrument which begins to quantify these experiences. The instrument, the Living with Medicines Questionnaire, was generated using qualitative findings with patients, to reflect their perspective. Further development is ongoing, involving researchers in multiple countries.

Keywords

Burden of illness Medication therapy management Patient perspective Polypharmacy Tool development 

Notes

Funding

Preliminary work on the instrument was funded by Liverpool John Moores University.

Conflicts of interest

The authors have no conflicts of interest to declare.

References

  1. 1.
    Salisbury C, Johnson L, Purgy S, Valderas JM, Montgomery AA. Epidemiology and impact of multimorbidity in primary care. A retrospective cohort study. Br J Gen Pract. 2011;61(582):e12–21.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Moynihan R, Doust J, Henry D. Preventing over-diagnosis: how to stop harming the healthy. BMJ. 2012;344:e3502.PubMedCrossRefGoogle Scholar
  3. 3.
    Hovstadius B, Petersson G. Factors leading to excessive polypharmacy. Clin Geriatr Med. 2012;28:159–72.PubMedCrossRefGoogle Scholar
  4. 4.
    Duerden M, Avery AJ, Payne R. Polypharmacy and medicines optimisation—making it safe and sound. London: The King’s Fund; 2013.Google Scholar
  5. 5.
    Gnjidic D, Le Couter DG, Pearson S-A, McLachlan AJ, Viney R, Hilmer SN, Blyth FM, Joshy G, Banks E. High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population level. BMC Public Health. 2013;13:115. doi: 10.1186/1471-2458-13-115.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Morgan T, Williamson M, Pirotta M, Stewart K, Myers SP, Barnes JA. National census of medicines use: a 24-hour snapshot of Australians aged 50 years and older. Med J Aust. 2012;196:50–3.PubMedCrossRefGoogle Scholar
  7. 7.
    Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated review. J Gerontol Nurs. 2005;31:4–11.PubMedCrossRefGoogle Scholar
  8. 8.
    May M, Montori V, Mair F. We need minimally disruptive medicine. BMJ. 2009;339:485–7.CrossRefGoogle Scholar
  9. 9.
    Sav A, Kendall E, Mc Millan SS, Kelly F, Whitty JA, King MA, Wheeler AJ. ‘You say treatment, I say hard work’: treatment burden among people with chronic illness and their carers in Australia. Health Soc Care Commun. 2013;21(6):665–74.Google Scholar
  10. 10.
    Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61(1):133–55.PubMedCrossRefGoogle Scholar
  11. 11.
    Reeve E, Weiss MD, Hendrix I, Roberts MS, Shakib S. People’s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriat Soc. 2013;61:1508–14.PubMedCrossRefGoogle Scholar
  12. 12.
    Olsson IN, Runnamo R, Engfeldt P. Medication quality and quality of life in the elderly, a cohort study. Health Qual Life Outcomes. 2011;9:95.PubMedCrossRefGoogle Scholar
  13. 13.
    Morecroft CW, Cantrill J, Tully MP. Patients’ evaluation of the appropriateness of their hypertension management—a qualitative study. Res Soc Admin Pharm. 2006;2:186–211.CrossRefGoogle Scholar
  14. 14.
    Moen J, Bohm A, Tillenius T, Antonov K, Nilsson JLG, Ring L. I don’t know how many of these [medicines] are necessary. A focus group study among elderly users of multiple medicines. Patient Educ Couns. 2008;74:135–41.PubMedCrossRefGoogle Scholar
  15. 15.
    Krska J, Morecroft CW, Poole H, Rowe PH. Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study. Int J Clin Pharm. 2013;35(6):1161–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Pharmaceutical Services Negotiating Committee. Medicines Use Review service. http://www.psnc.org.uk/pages/mur.html. Accessed 07 Feb 2014.
  17. 17.
    Australian Government Department of Human Services. Home medicines review service. https://www.medicareaustralia.gov.au/provider/pbs/fourth-agreement/hmr.jsp. Accessed 7 Feb 2014.
  18. 18.
    American Pharmacists Association and National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice. 2008. http://www.pharmacist.com/sites/default/files/files/core_elements_of_an_mtm_practice.pdf. Accessed 7 Feb 2014.
  19. 19.
    Royal Pharmaceutical Society. Medicines optimisation: helping patients make the most of medicines. London: RPS; 2013. http://www.rpharms.com/promoting-pharmacy-pdfs/helping-patients-make-the-most-of-their-medicines.pdf. Accessed 7 Feb 2014.
  20. 20.
    Krska J, Rowe PH. Outcome measures: a sensitive approach. Int J Pharm Pract. 2010;18:125–7.PubMedGoogle Scholar
  21. 21.
    Elliott RA, Marriott JL. Standardised assessment of patients’ capacity to manage medications: a systematic review of published instruments. BMC Geriatr. 2009;9:27.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Eton DT, Elraiyah TA, Yost KJ, Ridgeway LJ, Johnson A, Eggington JS, et al. A systematic review of patient-reported measures of burden of treatment in three chronic diseases. Patient Relat Outcome Meas. 2013;4:7–20.PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Blalock SJ, Patel RA. Drug therapy concerns questionnaire: Initial development and refinement. J Am Pharm Assoc. 2005;45:160–9.CrossRefGoogle Scholar
  24. 24.
    Rowe PH, Krska J. Satisfaction with medicines: the views of elderly patients. Int J Pharm Pract. 2008;16(suppl 1):A3.Google Scholar
  25. 25.
    Krska J, Morecroft CW, Poole H, Rowe PH. A novel instrument to measure medicines-related quality of life. Int J Clin Pharm. 2013;35:488.CrossRefGoogle Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2014

Authors and Affiliations

  • Janet Krska
    • 1
    Email author
  • Charles W. Morecroft
    • 2
  • Philip H. Rowe
    • 2
  • Helen Poole
    • 3
  1. 1.School of PharmacyUniversities of Greenwich and KentChatham Maritime, KentUK
  2. 2.School of Pharmacy and Biomolecular SciencesLiverpool John Moores UniversityLiverpoolUK
  3. 3.School of Natural Sciences and PsychologyLiverpool John Moores UniversityLiverpoolUK

Personalised recommendations